MRS. MAGGIE CROSSWY for KELLEY DRYE & WARREN LLP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA), FDA's technical assistance on DAIA, and discussion draft of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Lab Fee Schedule
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAGGIE CLARKE CROSSWY | — |
Environment/Superfund ENV
Issues related to water infrastructure procurement; FY19 Interior / Environment appropriations bills (H.R. 6147 / S. 3073) and provisions related to materials procurement for federal-aid projects; S. 3021 / S. 2800, America's Water Infrastructure Act of 2018 / H.R. 8, Water Resources Development Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAGGIE CLARKE CROSSWY | — |
Trade (domestic/foreign) TRD
Federal trade policy as it relates to unfair trade practices and trade law enforcement
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAGGIE CLARKE CROSSWY | — |
Transportation TRA
Issues related to transportation infrastructure and procurement, including reauthorization of federal transportation programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MAGGIE CLARKE CROSSWY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.